Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28476303 | 0.82 | ALOX15 (0.42) | ALDH1A1MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL17822155 | 0.79 | MEN1 (0.40) | ALDH1A1MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL7703195 | 0.74 | MEN1 (0.42) | ALDH1A1MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL3890589 | 0.74 | MEN1 (0.42) | ALDH1A1MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL1784052 | 0.74 | HIF1A (0.40) | ALDH1A1ALOX15 | |
| SCHEMBL1786594 | 0.73 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL1783631 | 0.73 | ALDH1A1 (0.43) | ALDH1A1 | |
| SCHEMBL11763330 | 0.72 | ALOX15 (0.39) | ALDH1A1MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL905182 | 0.71 | — | — | |
| SCHEMBL17381336 | 0.71 | ALDH1A1 (0.42) | ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3230245-B1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FLAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2020-06-10 | — | — | EP | disclosed |
| US-10450532-B2 | Organic compounds and their use as fragrance ingredients | GIVAUDAN S.A. (CH) | 2019-10-22 | — | — | US | disclosed |
| US-20170327769-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FRAGRANCE INGREDIENTS | GIVAUDAN S.A. (CH) | 2017-11-16 | — | — | US | disclosed |
| EP-3230245-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FLAGRANCE INGREDIENTS | Givaudan SA (CH) | 2017-10-18 | — | — | EP | disclosed |
| WO-2016091895-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FLAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2016-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10450532-B2 | Organic compounds and their use as fragrance ingredients | C9, C5, HRH1 | ALDH1A1 648/4885MEN1 1500/4885CYP3A4 567/4885 |
| US-20170327769-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FRAGRANCE INGREDIENTS | C5, C9, DHCR24 | ALDH1A1 693/4885MEN1 965/4885CYP3A4 811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.